Loan & DebtApr 7, 2026, 04:06 PM
Aimei Health Technology Extends Business Combination Deadline to May 6, 2026, Secures $34,330.96 in Sponsor Funding
AI Summary
Aimei Health Technology Co., Ltd. (AFJK) has announced a one-month extension for the consummation of its initial business combination, moving the new termination date to May 6, 2026. This marks the seventeenth such extension, indicating a prolonged process in finalizing its merger. To facilitate this extension, an aggregate of $34,330.96 was deposited into the company's trust account for public shareholders. The funding was provided through an unsecured promissory note issued to its Sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., the target company, ensuring the SPAC maintains its public listing while it continues to pursue the deal.
Key Highlights
- Aimei Health Technology Co., Ltd. extended its deadline to consummate an initial business combination by one month, from April 6, 2026, to May 6, 2026.
- An aggregate of $34,330.96 was deposited into the company's trust account for public shareholders, representing the seventeenth extension permitted under its Amended and Restated Articles of Association.
- The extension payment was funded by an unsecured promissory note in the total principal amount of $34,330.96.
- The Promissory Note was issued to Aimei Health Ltd (Sponsor) and United Hydrogen Group Inc., with each contributing $17,165.48.
- The Promissory Note does not bear interest and becomes due and payable upon the consummation of a business combination with United Hydrogen.
- The Payees have the right, but not the obligation, to convert the Promissory Note into private units of the Company at a price of $10.00 per unit, each consisting of one ordinary share and one right.
Price Impact
More from AFJK